Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy
Table 1
Patient demographics and baseline ocular findings.
Characteristic
No. (%) or median (range)
value
Sex: male/female
22/26 (45.8/54.2)
0.80
Age (y)
57 (37–75)
0.39
Duration of diabetes (y)
14 (3–33)
0.97
Fasting blood glucose (mmol/L)
6.9 (5–8.5)
0.52
HbA1c (%)
7.5 (5.4–10.3)
0.40
Hypertension
32 (66.7)
0.86
Serum creatinine (mg/dL)
0.89 (0.27–9.2)
0.74
Oral anticoagulant
19 (39.6)
0.81
Preoperative BCVA (logMAR†)
1.73 (0.4–2.6)
0.72
Preoperative IOP (mmHg)
15 (11–22)
0.88
Cataract
15 (31.2)
0.43
Pseudophakia
10 (20.8)
0.22
Previous PRP‡
20 (41.7)
0.87
Vitreous hemorrhage
44 (91.7)
0.54
Fibrovascular proliferation
43 (89.6)
0.48
Traction retinal detachment
23 (47.9)
0.82
Hb, hemoglobin; †MAR, logarithm of minimal angle of resolution; ‡PRP, panretinal photocoagulation; in this table means no statistically significant differences were found among the four groups.
